By Giedrė Peseckytė
Copyright politico
Social and cultural barriers: The Commission’s Marco Marsella, head of digital at DG SANTE, name-checked a recently published study on the adoption of AI in health care, which analyzed the benefits but also the barriers to its uptake, including cultural and social.
The ‘Brussels effect’: If Europe can prove AI’s value in health care, it could set an example for the rest of the world, said Afua van Haasteren, director for health policy and external affairs at Roche. “We know the EU sets the tone … If we can really ensure these AI technologies are trustworthy across the EU, we foresee an uptake across the world,” she said.
The patient voice: AI developers should involve patients from the start to help build trust in the tech, said Valentina Strammiello, interim executive director at the European Patients’ Forum. Unfortunately, she added, SMEs are often unaware of the benefits of having patients involved, meaning more education is needed.
Summing up: “Innovation will move at the speed of trust,” concluded Ricardo Baptista Leite, CEO of non-profit Health AI.
**A message from EFPIA: One in two cardiovascular patients struggle to stick to their treatment. Supporting better adherence is essential to improving outcomes, preventing complications, and enhancing quality of life for people living with cardiovascular disease.**
MEANWHILE IN BRUSSELS: The European Commission wants to boost the use of AI in biotech research, according to a draft of the European Strategy for Artificial Intelligence in Science, seen by our tech colleague Pieter Haeck.
About the strategy: The strategy highlights how the adoption of AI in science “will have profound scientific, economic and social implications” and offers key actions to unlock its potential. They include boosting investments in AI in science and launching a virtual lab. Pieter has more.